11:19 AM EST - Oncolytics Biotech® Inc. : Today announced publication of an abstract on pelareorep (formerly known as REOLYSIN) for the European Society for Medical Oncology (ESMO) 2018 Congress, taking place October 19-23 in Munich. Oncolytics Biotech® Inc.
shares T.ONC are trading up $0.03 at $4.46.
